HealthEquity, Inc. $HQY Shares Acquired by Oppenheimer Asset Management Inc.

Oppenheimer Asset Management Inc. boosted its position in shares of HealthEquity, Inc. (NASDAQ:HQY) by 4.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 161,702 shares of the company’s stock after purchasing an additional 6,159 shares during the period. Oppenheimer Asset Management Inc.’s holdings in HealthEquity were worth $14,814,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in HQY. Capricorn Fund Managers Ltd bought a new stake in shares of HealthEquity during the fourth quarter valued at approximately $6,926,000. 12th Street Asset Management Company LLC increased its holdings in shares of HealthEquity by 114.4% in the third quarter. 12th Street Asset Management Company LLC now owns 272,068 shares of the company’s stock valued at $25,784,000 after buying an additional 145,151 shares in the last quarter. Bessemer Group Inc. increased its holdings in shares of HealthEquity by 21.3% in the third quarter. Bessemer Group Inc. now owns 349,342 shares of the company’s stock valued at $33,108,000 after buying an additional 61,317 shares in the last quarter. JPMorgan Chase & Co. increased its holdings in shares of HealthEquity by 11.5% in the third quarter. JPMorgan Chase & Co. now owns 1,205,077 shares of the company’s stock valued at $114,205,000 after buying an additional 124,283 shares in the last quarter. Finally, GDS Wealth Management increased its holdings in shares of HealthEquity by 15.7% in the third quarter. GDS Wealth Management now owns 100,969 shares of the company’s stock valued at $9,569,000 after buying an additional 13,682 shares in the last quarter. 99.55% of the stock is owned by institutional investors and hedge funds.

HealthEquity Stock Up 0.5%

Shares of HQY opened at $82.40 on Friday. The company has a 50-day simple moving average of $80.91 and a 200-day simple moving average of $88.04. The firm has a market capitalization of $6.96 billion, a P/E ratio of 33.50, a P/E/G ratio of 1.49 and a beta of 0.19. The company has a debt-to-equity ratio of 0.45, a quick ratio of 3.27 and a current ratio of 3.27. HealthEquity, Inc. has a 52 week low of $72.76 and a 52 week high of $116.65.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings data on Tuesday, March 17th. The company reported $0.95 EPS for the quarter, beating analysts’ consensus estimates of $0.90 by $0.05. HealthEquity had a net margin of 16.39% and a return on equity of 13.86%. The business had revenue of $334.59 million during the quarter, compared to analyst estimates of $332.48 million. The business’s quarterly revenue was up 7.3% compared to the same quarter last year. On average, equities research analysts expect that HealthEquity, Inc. will post 3.84 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on HQY shares. JPMorgan Chase & Co. lowered their price objective on shares of HealthEquity from $129.00 to $123.00 and set an “overweight” rating on the stock in a research report on Wednesday, March 18th. The Goldman Sachs Group cut shares of HealthEquity from a “neutral” rating to a “sell” rating and set a $89.00 price objective on the stock. in a research report on Friday, January 9th. Barclays lowered their price objective on shares of HealthEquity from $118.00 to $110.00 and set an “overweight” rating on the stock in a research report on Wednesday, February 18th. Weiss Ratings reiterated a “hold (c+)” rating on shares of HealthEquity in a research report on Thursday, January 22nd. Finally, UBS Group set a $110.00 price target on shares of HealthEquity in a report on Tuesday, February 17th. One investment analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, HealthEquity presently has an average rating of “Moderate Buy” and an average price target of $111.79.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.